Immunotherapy: A new option for advanced prostate cancer
A diagnosis of cancer is always frightening. Once the shock wears off, patients have to decide what to do next. And for most of the estimated 192,000 American men who will be diagnosed with prostate cancer this year, the decisions can be nearly as overwhelming as the diagnosis itself. Because scientific studies have not established which treatments are best, patients with early prostate cancer are asked to choose between deferred treatment (watchful waiting or active surveillance); surgery (conventional, laparoscopic, or robot-assisted); and radiation (external beam, proton beam, or brachytherapy with implanted radioactive seeds, with or without hormone therapy). To make matters even more confusing, some men also consider less established, experimental treatments, ranging from cryotherapy and high-frequency ultrasound to microwave or radiofrequency tumor ablation and lifestyle treatment using diet and supplements.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
